2004
DOI: 10.1007/s00044-004-0118-3
|View full text |Cite
|
Sign up to set email alerts
|

Production of Antibacterial and Antifungal Metabolites by Streptomyces Violaceusniger and Media Optimization Studies for the Maximum Metabolite Production

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
1
2

Year Published

2007
2007
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 23 publications
(21 citation statements)
references
References 0 publications
0
18
1
2
Order By: Relevance
“…It is important to clarify the taxonomy of S. hygroscopicus, S. violaceusniger and related strains, not least because members of the S. violaceusniger 16S rRNA gene clade are a source of antibacterial and antifungal metabolites (DeBoer et al 1970;Lam et al 1990;Tripathi et al 2004), biological control agents (TrejoEstrada et al 1998a, b;Chamberlain and Crawford 1999), enantioselective biocatalysts (Molinari et al 2005) and immunosuppressants, including rapamycin (Vezina et al 1975). Authenticated members of the S. violaceusniger 16S rRNA gene clade show the same pattern of HPLC-detected secondary metabolites, namely eliaophylin, geldanamycin, nigericin and a polyene (Ward and Goodfellow 2004), a result consistent with those of earlier studies (Allen and Ritchie 1994; Fang et al 2000).…”
Section: Introductionmentioning
confidence: 99%
“…It is important to clarify the taxonomy of S. hygroscopicus, S. violaceusniger and related strains, not least because members of the S. violaceusniger 16S rRNA gene clade are a source of antibacterial and antifungal metabolites (DeBoer et al 1970;Lam et al 1990;Tripathi et al 2004), biological control agents (TrejoEstrada et al 1998a, b;Chamberlain and Crawford 1999), enantioselective biocatalysts (Molinari et al 2005) and immunosuppressants, including rapamycin (Vezina et al 1975). Authenticated members of the S. violaceusniger 16S rRNA gene clade show the same pattern of HPLC-detected secondary metabolites, namely eliaophylin, geldanamycin, nigericin and a polyene (Ward and Goodfellow 2004), a result consistent with those of earlier studies (Allen and Ritchie 1994; Fang et al 2000).…”
Section: Introductionmentioning
confidence: 99%
“…Natural products have long been used as templates for the design of new lead compounds which may be useful against infectious diseases, such as blactams, tetracyclins, echinocandins, and macrolydes (Newman and Cragg, 2007). In this context, several metabolites of different structural patterns have proven active against microorganisms, and screening of extracts is a valid strategy being exploited to discover novel antimicrobial agents (Acharya et al, 2008;Singh et al, 2008;Tripathi et al, 2004;Viswanathan et al, 2004;Wang et al, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…It is evident from the present study that representatives of over 40 new streptomycete species were detected in the small clone library (45 clones) generated from the six different environmental samples. It is reasonable to conclude that the new phyletic lines share a common history with organisms known to be a rich source of new bioactive compounds (Vezina et al , 1975; Kino et al , 1987; Tripathi et al , 2004; Ward & Goodfellow, 2004). This diversity already exceeds that of the current cultivable components of the S. violaceusniger 16S rRNA gene clade, thereby highlighting the biotechnological potential and ecological significance of members of this taxon.…”
Section: Discussionmentioning
confidence: 99%